Journal
PLoS One
Publication Date
2017
Volume
12
Issue
7
Inclusive Pages
e0179558
Document Type
Open Access Publication
DOI
10.1371/journal.pone.0179558
Rights and Permissions
Bandyopadhyay S, Li J, Traer E, Tyner JW, Zhou A, et al. (2017) Cholesterol esterification inhibition and imatinib treatment synergistically inhibit growth of BCR-ABL mutation-independent resistant chronic myelogenous leukemia. PLOS ONE 12(7): e0179558. https://doi.org/10.1371/journal.pone.0179558
Recommended Citation
Bandyopadhyay, Shovik; Li, Junjie; Traer, Elie; Tyner, Jeffrey W.; Zhou, Amy; Oh, Stephen T.; and Cheng, Ji-Xin, "Cholesterol esterification inhibition and imatinib treatment synergistically inhibit growth of BCR-ABL mutation-independent resistant chronic myelogenous leukemia." PLoS One. 12, 7. e0179558. (2017).
https://digitalcommons.wustl.edu/open_access_pubs/6118
Figure S1.docx (355 kB)
Figure S1
Figure S2.docx (30 kB)
Figure S2
Figure S3.docx (437 kB)
Figure S3
Figure S4.docx (289 kB)
Figure S4
Figure S5.docx (23 kB)
Figure S5
Figure S6.docx (573 kB)
Figure S6
Figure S7.docx (481 kB)
Figure S7
Table S1.xlsx (12 kB)
Table S1
Figure S1
Figure S2.docx (30 kB)
Figure S2
Figure S3.docx (437 kB)
Figure S3
Figure S4.docx (289 kB)
Figure S4
Figure S5.docx (23 kB)
Figure S5
Figure S6.docx (573 kB)
Figure S6
Figure S7.docx (481 kB)
Figure S7
Table S1.xlsx (12 kB)
Table S1
